Phase 2 Sjogren's Syndrome Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Sjogren's Syndrome
National Institute of Dental and Craniofacial Research (NIDCR)60 enrolled1 locationNCT07281456
Recruiting
Phase 1Phase 2
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
Sjogren's Syndrome
Peking Union Medical College Hospital60 enrolled1 locationNCT07062523
Recruiting
Phase 1Phase 2
Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome
LymphomaPrimary Sjogren's Syndrome
Bangdong Gong6 enrolled1 locationNCT06967038
Recruiting
Phase 1Phase 2
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Systemic Lupus ErythematosusSjogren's SyndromeAutoimmune Diseases+1 more
Essen Biotech60 enrolled1 locationNCT06428188
Recruiting
Phase 1Phase 2
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisSjogren's Syndrome+6 more
Essen Biotech75 enrolled1 locationNCT06350110
Completed
Phase 2
Surfactant for Obstructive Sleep Apnea in Patients with Primary Sjogren’s Syndrome: A randomised, placebo controlled study.
obstructive sleep apnea in patients with primary sjogren's syndrome.
Adelaide Institute for Sleep Health14 enrolled1 locationACTRN12612000113853